Alamar Biosciences, Inc. (ALMR)

NASDAQ: ALMR · Real-Time Price · USD

23.96

+0.30 (1.27%)

At close: May 8, 2026, 4:00 PM EDT

24.43

+0.47 (1.96%)

After-hours: May 8, 2026, 6:27 PM EDT

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Diagnostic Kits / Equipment	74.21M	25.14M
Diagnostic Kits / Equipment Growth	195.17%	-
Total	74.21M	25.14M
Total Growth	195.17%	-

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
United States	45.42M	14.55M
United States Growth	212.08%	-
Europe, Middle East and Africa (Excluding Germany)	14.12M	5.65M
Europe, Middle East and Africa (Excluding Germany) Growth	149.81%	-
Germany	8.31M	4.42M
Germany Growth	88.01%	-
Asia Pacific	5.82M	486.00K
Asia Pacific Growth	1098.35%	-
Rest of The World	539.00K	30.00K
Rest of The World Growth	1696.67%	-
Total	74.21M	25.14M
Total Growth	195.17%	-

Source: S&P Global Market Intelligence.